Fetal exposure to the perfluoroalkyl acids, perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA), has been associated with lower birth weight and lower weight and body mass index (weight (kg)/height (m)
Perfluoroalkyl acids are widely used in industry and consumer products because of their repellent properties and low surface tension (1) . Among the class of perfluoroalkyl acids, perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) are some of the most environmentally ubiquitous compounds (1) . The half-lives of PFOS and PFOA are 4-5 years in humans (2) . In pregnant and breastfeeding women, the elimination is, however, faster because of placental transport to the fetus or via breast milk to the infant (3) (4) (5) .
In humans, prenatal exposure to PFOS and PFOA has been associated with smaller size at birth (3, 6, 7) , supported by animal studies (8) (9) (10) . From a random sample within the Danish National Birth Cohort, inverse associations have been reported between prenatal exposure to PFOS or PFOA and birth weight measures (11, 12) and weight and body mass index during infancy in boys but not in girls (13) . In contrast, prenatal exposure to PFOA has been suggested to increase the risk of obesity in both humans (14) and rodents (15) in young adulthood.
It is unclear if prenatal exposures to PFOS and PFOA have any influences on childhood anthropometry. Therefore, in this study, we investigated if PFOS and PFOA, measured in maternal plasma in early pregnancy, were associated with children's body mass index, waist circumference, and risk of overweight at 7 years of age, and if any relationships were modified by sex.
Briefly, women were recruited from all over Denmark at the first antenatal care visit to their general practitioner. Two blood samples were collected in the first and second trimesters, respectively, and a blood sample was retrieved from the umbilical cord at birth. The women participated in 4 computer-assisted telephone interviews: twice during pregnancy at week 16 and week 30 (Interview 1 and Interview 2) and twice after birth at 6 months and 18 months postpartum (Interview 3 and Interview 4). A follow-up study of the children was furthermore conducted. During the month the child turned 7 years of age, the parents were asked to fill in a mailed or Web-based questionnaire, including the latest height and weight, and to measure the child's waist circumference. Around 60% responded to the 7-year-follow-up (18) . All questionnaires are available on the following website (www. dnbc.dk).
In previous studies (11, 12) , 1,400 mothers were randomly selected from among all participants who gave birth to a liveborn singleton without congenital malformations (n = 87,752), provided the first blood sample (n = 80,678), and took part in all 4 telephone interviews (n = 43,045).
For the present study, children of the 1,400 mothers were eligible if they had information available about weight and height (n = 811) or waist measurements (n = 804) at 7 years of age.
All participants provided written, informed consent when they were enrolled in the cohort. The Scientific Ethics Committee in Denmark, the Danish Data Protection Board, and the Danish National Birth Cohort Steering Committee approved the study.
Exposure variables and covariates
Plasma concentrations of PFOS and PFOA were measured by using high-performance liquid chromatography tandem mass spectrometry in the 3M Toxicology Laboratory (19) . Further information about extractions and methods is presented elsewhere (11, 19) . Interview 1 provided information about self-reported prepregnancy weight and height, which was used to calculate prepregnancy body mass index, age at conception, parity, smoking during pregnancy, and socioeconomic status defined by education and occupation. In Interview 3, the mothers informed about duration of breastfeeding, and in Interview 4, they reported the weight of their child at 5 months and 12 months of age, measured by the general practitioner. Information about birth weight and gestational age was obtained from the National Birth Register.
Outcome variables
The outcome variables were the children's body mass index, waist circumference, and risk of overweight at 7 years of age. Body mass index was calculated from the weight and height measurements, where 33% of the measurements were made by the school physician, public health nurses, or general practitioner and 67% by another person (usually one of the parents). It was treated as a continuous and a dichotomized variable (normal weight or overweight), according to the International Obesity Task Force standards with age-and sex-specific cutpoints (20) . These cutpoints were provided at exact half-year ages from 2.0 to 18.0 years. The cutpoints for overweight at 7 years of age for boys and girls are 17 a Missing data on prepregnancy BMI (n = 22), birth weight (n = 9), BMI at 5 months (n = 138), BMI at 12 months (n = 179), and socioeconomic status (n = 2). was 11%, and only 2% were obese. Therefore, overweight and obese children were grouped together.
Statistical analysis
Multiple linear regression analyses were used to study associations between the maternal level of PFOS or PFOA and the children's anthropometry. After log-transformation due to a nonnormal distribution, body mass index and waist circumference were standardized into z scores by using sexand age-specific internal references. All analyses were done separately for boys and girls, although sex did not modify any associations between exposure and outcome (all P > 0.1). Levels of PFOS and PFOA were used as continuous and categorical variables (<25th, 25th-<50th, 50th-<75th, and ≥75th percentiles). The lowest quartile was used as the reference group.
The following covariates were chosen a priori and included in the fully adjusted models: child's exact age at measurements, maternal age, parity (0, 1, 2, ≥3), prepregnancy body mass index, smoking during pregnancy (nonsmokers, quit smoking during pregnancy, 1-9 cigarettes/ day, or ≥10 cigarettes/day), socioeconomic status (high, middle, or low), and gestational week at blood drawing. All covariates were included as continuous variables, except parity, smoking, and socioeconomic status. In additional analyses, gestational weight gain, child's birth weight, duration of breastfeeding (0-13 weeks, 14-21 weeks, or ≥22 weeks), and weight at 5 and 12 months of age were also included. The waist/height ratio may be an indicator of cardiometabolic risk (21) , and supplementary analyses were performed by using waist-to-height residuals as outcome variables.
To investigate the high end of the body mass index distribution, we performed multiple logistic regression analyses, using the aforementioned adjustment strategy. Because children with early versus late adiposity rebound will have different body mass indexes at 7 years of age (22) , additional logistic regression analyses for children between 4.4 and 6.9 years (n = 159) and between 7.0 and 8.4 years of age (n = 680) were performed.
All statistical analyses were done in Intercooled STATA, version 9.0, software (StataCorp LP, College Station, Texas).
RESULTS
The study population is described in Table 1 . The demographics of the present population did not differ from those of the initial random sample of the 1,400 women with regard to the plasma level of PFOS or PFOA, maternal age, prepregnancy body mass index, gestational weight gain, or any growth measures of the child (all P > 0.1) (data not shown). When comparing the present population with all participants in the 7-year-follow-up study, we found no significant differences in the children's growth measurements during infancy or at 7 years (all P > 0.1), whereas the mothers were slightly older, had a higher prepregnancy body mass index, and gave birth to children with higher birth weights than all mothers participating in the follow-up study (all P < 0.04) (data not shown). The results from the additional analyses using waist-for-height residuals as outcome were very similar to the main results. In adjusted linear regression analyses, PFOS and PFOA were inversely associated with body mass index in boys and girls even though all estimates were nonsignificant ( Table 2) . The same results were seen between PFOS and PFOA and the waist circumference in boys, whereas no clear pattern was observed in the girls (Table 2 ). It is noteworthy that the crude associations did not differ from the adjusted ones. No evidence for dose-response relationships was seen (Table 3) , and PFOS and PFOA did not seem to either increase or decrease the risk of overweight in boys or girls (Table 4) .
Additional adjustment for total gestational weight gain, birth weight, weight at 5 months, and weight at 12 months and breastfeeding in any of the above-mentioned analyses did not change the results (data not shown).
DISCUSSION
Maternal plasma levels of PFOS and PFOA were inversely associated with the children's body mass index and waist circumference at 7 years of age, but none of the associations was statistically significant. Furthermore, PFOS and PFOA exposures did not increase the risk of overweight. Prenatal exposure to perfluoroalkyl acids may reduce the infancy weight and body mass index in boys (13) , but the present results suggest that a growth deficit may be recovered between infancy and childhood.
A unique strength of the study is the data from a welldescribed nation-wide birth cohort (16) , with a prospective collection of important information about mothers and children and assessment of perfluoroalkyl acids early in pregnancy. High-standard techniques were furthermore used to measure values of PFOS and PFOA. Although the outcomes were based on self-reported information, an earlier validation study showed that the growth measurements done by parents were comparable to those done by school physicians (23) .
The initial population of 1,400 women was randomly selected from the entire Danish National Birth Cohort and did not differ significantly from the present cohort concerning the included confounding factors (data not shown). The 1,400 women had slightly higher maternal plasma levels of PFOA and PFOS than other pregnant populations (4, 24, 25) , which probably reflects differences in time, populations, or laboratory techniques. The risk of selection bias is low, because the women were included long before the outcome of interest. However, the mothers in the present sample were older, had a higher prepregnancy body mass index, and had children with higher birth weights compared with those in the 7-year-follow-up sample. Older maternal ages could be associated with higher plasma levels of PFOS and PFOA and, thereby, also lower birth weights in the infants (11) , but this was not the case. There is no reason to believe that the observed associations depend on the particular characteristics of the study population. Given the design and methodology of the study and the overall narrow confidence intervals, the results do not provide evidence for an influence from prenatal exposure to PFOS or PFOA on childhood anthropometry or risk of overweight at 7 years of age. Evidence on environmental exposure to perfluoroalkyl acids and childhood anthropometry is sparse. One study reported that serum levels of PFOA in girls aged 6-7 years were inversely associated with their body mass index 1 year later at follow-up (26) . The girls were enrolled during the years 2004-2006 and were heterogeneous in ethnicity and demographics (Susan Pinney, University of Cincinnati College of Medicine, personal communication, 2012). It is plausible that exposures to perfluoroalkyl acids in fetal life have less influence on the childhood anthropometry than perfluoroalkyl acids from the environment where the child grows up (27) (28) (29) , which may explain the present results. However, it was recently shown that prenatal exposure to PFOA may increase the risk of obesity and waist circumference in women aged 20 years (14) , suggesting that in utero exposure to some endocrine disruptors may have long latency periods before consequences are manifested. Such a latency period has been proposed for maternal smoking during pregnancy in relation to accumulation of intraabdominal fat in the offspring (30) . PFOS and PFOA might also interfere with the pubertal maturation processes and thereby first influence the risk of overweight when hormone levels are increasing during adolescence (31) . Furthermore, the perfluoroalkyl acids were not associated with decreased infancy weight in girls in our previous study (13) , indicating catch-up growth during the first months of life, which may increase the risk of later overweight (32) . Additionally, the women in the present study had slightly higher levels of PFOA, which might influence the offspring differently from lower exposure levels, which has been reported for other chemicals (33) . Some studies have found that relatively low prenatal exposure levels of polychlorinated biphenyls were associated with increased body mass index and weight in early childhood (34, 35) , whereas higher levels were related to lower childhood weight (36, 37) . Our results indicate that this might also be the case for especially PFOS in relation to body mass index and waist circumference. Still, neither of the associations between PFOS or PFOA and the anthropometry differed significantly from linearity, but this needs to be confirmed in future studies.
In summary, this study does not indicate any strong link between prenatal exposure to PFOS or PFOA and body mass index, waist circumference, or risk of overweight in boys or girls 7 years of age.
